FIS1
gene geneOn this page
Also known as CGI-135H_NH0132A01.6
Summary
FIS1 (fission, mitochondrial 1, HGNC:21689) is a protein-coding gene on chromosome 7q22.1, encoding Mitochondrial fission 1 protein (Q9Y3D6). Involved in the fragmentation of the mitochondrial network and its perinuclear clustering. It is a selective cancer dependency (DepMap: 24.4% of cell lines).
Enables identical protein binding activity; lipid binding activity; and molecular adaptor activity. Involved in several processes, including negative regulation of ATP metabolic process; negative regulation of fatty acid transport; and organelle fission. Acts upstream of or within mitochondrion organization. Located in mitochondrial outer membrane and peroxisomal membrane. Part of protein-containing complex. Biomarker of Alzheimer’s disease.
Source: NCBI Gene 51024 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 34 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 24.4% of screened cell lines
- MANE Select transcript:
NM_016068
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21689 |
| Approved symbol | FIS1 |
| Name | fission, mitochondrial 1 |
| Location | 7q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CGI-135, H_NH0132A01.6 |
| Ensembl gene | ENSG00000214253 |
| Ensembl biotype | protein_coding |
| OMIM | 609003 |
| Entrez | 51024 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 12 protein_coding, 3 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay
ENST00000223136, ENST00000435848, ENST00000442303, ENST00000449367, ENST00000463406, ENST00000473527, ENST00000474120, ENST00000480497, ENST00000482199, ENST00000902740, ENST00000902741, ENST00000902742, ENST00000920970, ENST00000920971, ENST00000920972, ENST00000920973, ENST00000955058
RefSeq mRNA: 1 — MANE Select: NM_016068
NM_016068
CCDS: CCDS43626
Canonical transcript exons
ENST00000223136 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000881583 | 101244960 | 101245081 |
| ENSE00003489249 | 101240830 | 101240906 |
| ENSE00003528179 | 101240142 | 101240247 |
| ENSE00003598790 | 101239472 | 101239903 |
| ENSE00003610157 | 101244007 | 101244139 |
Expression profiles
Bgee: expression breadth ubiquitous, 284 present calls, max score 99.35.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 92.5603 / max 414.2169, expressed in 1828 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 85328 | 80.3712 | 1827 |
| 85330 | 6.0722 | 1732 |
| 85329 | 4.9306 | 1713 |
| 85327 | 0.7484 | 390 |
| 85325 | 0.3597 | 32 |
| 85324 | 0.0488 | 15 |
| 85326 | 0.0295 | 5 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| C1 segment of cervical spinal cord | UBERON:0006469 | 99.35 | gold quality |
| apex of heart | UBERON:0002098 | 99.22 | gold quality |
| spinal cord | UBERON:0002240 | 99.09 | gold quality |
| prefrontal cortex | UBERON:0000451 | 98.94 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 98.78 | gold quality |
| adenohypophysis | UBERON:0002196 | 98.70 | gold quality |
| gastrocnemius | UBERON:0001388 | 98.68 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 98.65 | gold quality |
| cingulate cortex | UBERON:0003027 | 98.64 | gold quality |
| right frontal lobe | UBERON:0002810 | 98.61 | gold quality |
| pituitary gland | UBERON:0000007 | 98.60 | gold quality |
| right atrium auricular region | UBERON:0006631 | 98.57 | gold quality |
| lower esophagus | UBERON:0013473 | 98.54 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 98.54 | gold quality |
| heart left ventricle | UBERON:0002084 | 98.53 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 98.52 | gold quality |
| mucosa of stomach | UBERON:0001199 | 98.51 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 98.51 | gold quality |
| muscle of leg | UBERON:0001383 | 98.50 | gold quality |
| cranial nerve II | UBERON:0000941 | 98.49 | gold quality |
| tibial nerve | UBERON:0001323 | 98.49 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 98.49 | gold quality |
| left adrenal gland | UBERON:0001234 | 98.45 | gold quality |
| cardiac ventricle | UBERON:0002082 | 98.43 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 98.42 | gold quality |
| metanephros cortex | UBERON:0010533 | 98.42 | gold quality |
| right adrenal gland | UBERON:0001233 | 98.39 | gold quality |
| amygdala | UBERON:0001876 | 98.39 | gold quality |
| nucleus accumbens | UBERON:0001882 | 98.39 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 98.38 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-4850 | no | 247.30 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting FIS1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-3175 | 99.65 | 66.30 | 2031 |
| HSA-MIR-4489 | 99.50 | 65.56 | 785 |
| HSA-MIR-6081 | 99.48 | 66.07 | 1446 |
| HSA-MIR-5589-3P | 99.29 | 68.30 | 1443 |
| HSA-MIR-4656 | 98.79 | 66.22 | 1306 |
| HSA-MIR-4717-5P | 98.19 | 67.97 | 894 |
| HSA-MIR-4518 | 98.12 | 66.82 | 1030 |
| HSA-MIR-1266-5P | 97.71 | 66.92 | 1052 |
| HSA-MIR-939-5P | 97.10 | 65.80 | 1579 |
| HSA-MIR-1343-5P | 96.48 | 66.06 | 1506 |
| HSA-MIR-3675-5P | 95.90 | 65.80 | 474 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 24.4% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 40)
- hFis1 is part of the mammalian fission machinery and regulation of the fission processes might be involved in apoptotic mechanisms (PMID:12783892)
- regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1 (PMID:12861026)
- Cytosolic domain of fis1 adopts a tetratricopeptide repeat domain fold. (PMID:14705031)
- the level of Fis1 at the mitochondrial surface influences mitochondrial fission events and hence overall mitochondrial morphology within the cell (PMID:14996942)
- hFis1 induces mitochondrial fragmentation and perinuclear clustering in a state of calcium homeostasis (PMID:15024001)
- Fis1, Drp1, and Opa1 have roles in apoptosis (PMID:15356267)
- Fis1 together with dynamin-related protein (Drp1) antogonizes Bcl-2. (PMID:16010987)
- These findings provide the first evidence for a role of Fis1 in peroxisomal fission and suggest that the fission machinery of mitochondria and peroxisomes shares common components. (PMID:16107562)
- TPR region of hFis1 participates in the interaction with DLP1 or DLP1-containing complex and that the first helix (alpha1) of hFis1 is required for mitochondrial fission presumably by regulating DLP1-hFis1 interaction. (PMID:16118244)
- Direct induction of mitochondrial elongation by blocking mitochondrial fission process with Fis1-DeltaTM or Drp1-K38A was sufficient to develop senescent phenotypes with increased Reactive oxygen species production. (PMID:16883569)
- hFis1 is a bifunctional protein that independently regulates mitochondrial fragmentation and endoplasmic reticulum-mediated apoptosis. (PMID:16914522)
- Fis1 plays important roles in peroxisome division and maintenance of peroxisome morphology in mammalian cells, possibly in a concerted manner with Pex11pbeta and DLP1. (PMID:17408615)
- hFis1 and OPA1 modulate cellular senescence (PMID:17545159)
- the concave surface of the Fis1 tetratricopeptide repeat-like domain is evolutionarily conserved to bind the dynamin-like GTPase Dnm1 and not Mdv1 as previously predicted (PMID:17884824)
- Changes correlate with mitochondrial dysfunction rather than with fragmentation, as substantiated by Fis1 mutants with different effects on organelle shape and function (PMID:18515060)
- targeting of hFis1 to peroxisomes and mitochondria are independent events and support a direct, Pex19p-dependent targeting of peroxisomal tail-anchored proteins. (PMID:18782765)
- Fis1 and Mfn1 activities influence mitochondrial signal generation thereby insulin exocytosis. (PMID:18832378)
- oligomerization of hFis1 in the mitochondrial outer membrane plays a role in mitochondrial fission, potentially through participating in fission factor recruitment. (PMID:18845145)
- hFis1 can bind to multiple amino acid sequences selectively, and the tetratricopeptide repeat constitutes the main binding region of hFis1. (PMID:19864424)
- There is a Drp1- and Fis1-induced, and PINK1-mediated protection mechanism in senescent cells. (PMID:20179104)
- we observed interactions between Drp1 and Fis1 in mitochondrial fragmentation induced by increasing mitochondrial calcium (PMID:20428767)
- The mitochondrial fission protein Fission 1 homologue (Fis1) conveys an apoptosis signal from the mitochondria to the ER by interacting with Bap31 at the ER and facilitating its cleavage into the pro-apoptotic p20Bap31. (PMID:21183955)
- Fis1 and dynamin-related protein (Drp)1 levels are remarkably increased in peripheral blood lymphocytes of Alzheimer’s disease patients. (PMID:22340708)
- PEX11 proteins attract both Mff and human Fis1 (hFis1) to their site of action. (PMID:22595523)
- Fis1 activity depends on its ability to interconvert between monomer and dimer species (PMID:22789569)
- Fis1 acts as a mitochondrial recruitment factor for TBC1D15 that is involved in regulation of mitochondrial morphology. (PMID:23077178)
- Fis1 expression is significantly increased in spinal cord in a transgenic mouse model of amyotrophic lateral sclerosis. (PMID:23713734)
- Overexpression of FoxM1 and Plk1 in Fis1-depleted cells restores mitotic entry. (PMID:23907611)
- MiD49 and MiD51 can act independently of Mff and Fis1 in Drp1 recruitment and suggest that they provide specificity to the division of mitochondria. (PMID:23921378)
- PDCD7, Ang2 and FIS1 may indicate a more aggressive form and poor prognosis of acute myeloid leukemia. (PMID:24416201)
- Results show that Fis1 is significantly overexpressed in malignant oncocytomas. (PMID:25822260)
- Study revealed that a novel mitochondrial fission pathway composed of miR-483-5p and FIS1 regulates cisplatin sensitivity. (PMID:25843291)
- Fis1 depletion in osteoarthritis impairs chondrocyte survival and peroxisomal and lysosomal function. (PMID:27497958)
- inhibition of Drp1/Fis1 interaction by a selective peptide inhibitor, P110, led to a significant reduction in reactive oxygen species levels, and to improvement in mitochondrial structure and functions. (PMID:29335339)
- data suggest a model in which leukemia stem cells co-opt AMPK/FIS1-mediated mitophagy as a means to maintain stem cell properties that may be otherwise compromised by the stresses induced by oncogenic transformation (PMID:29910151)
- we found that differential expression of BAK1, FIS1, and SFN were altered across the Barrett’s disease sequence and manipulation of these genes elicited significant effects on mitochondrial membrane potential. (PMID:30404157)
- FIS1 and PDCD7 expression are considered independent risk factors and should be integrated into the current acute myeloid leukemia stratification system (PMID:30555023)
- Glomerular overproduction of Drp1, phospho-Drp1 (Ser 616) and Fis1 occurred mainly in children with membranous nephropathy. (PMID:30566949)
- Study demonstrated that the STX17 initiates mitophagy upon depletion of outer mitochondrial membrane protein Fis1. Fis1 loss results in aberrant STX17 accumulation on mitochondria, which exposes the N terminus and promotes self-oligomerization to trigger mitophagy. Findings uncover a PINK1/Parkin-independent mitophagic mechanism in which outer mitochondrial membrane protein Fis1 regulates mitochondrial quality control. (PMID:31053718)
- In human EPCs, down-regulation of Fis1 is involved in mitochondrial dysfunction and contributes to the impaired activity of EPCs during the senescence process. Enhanced expression of Fis1 in senescent EPCs restores the youthful phenotype. (PMID:31482366)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fis1 | ENSDARG00000114549 |
| mus_musculus | Fis1 | ENSMUSG00000019054 |
| rattus_norvegicus | Fis1 | ENSRNOG00000001420 |
| drosophila_melanogaster | Fis1 | FBGN0039969 |
| caenorhabditis_elegans | WBGENE00001424 | |
| caenorhabditis_elegans | WBGENE00001425 |
Protein
Protein identifiers
Mitochondrial fission 1 protein — Q9Y3D6 (reviewed: Q9Y3D6)
Alternative names: FIS1 homolog, Tetratricopeptide repeat protein 11
All UniProt accessions (6): C9JXH1, F5H509, F5H8A8, F8WBT1, F8WD11, Q9Y3D6
UniProt curated annotations — full annotation on UniProt →
Function. Involved in the fragmentation of the mitochondrial network and its perinuclear clustering. Plays a minor role in the recruitment and association of the fission mediator dynamin-related protein 1 (DNM1L) to the mitochondrial surface and mitochondrial fission. May not be essential for the assembly of functional fission complexes and the subsequent membrane scission event. Also mediates peroxisomal fission. May act when the products of fission are directed toward mitochondrial homeostasis, mitophagy, or apoptosis. Can induce cytochrome c release from the mitochondrion to the cytosol, ultimately leading to apoptosis.
Subunit / interactions. Interacts with DNM1L/DLP1 through the TPR region; may form part of a larger protein complex at the endoplasmic reticulum-mitochondrial interface during mitochondrial fission. Interacts with MARCHF5. Interacts with MIEF1. Interacts with PEX11A, PEX11B and PEX11G.
Subcellular location. Mitochondrion outer membrane. Peroxisome membrane.
Post-translational modifications. Ubiquitinated by MARCHF5.
Domain organisation. The C-terminus is required for mitochondrial or peroxisomal localization, while the N-terminus is necessary for mitochondrial or peroxisomal fission, localization and regulation of the interaction with DNM1L.
Similarity. Belongs to the FIS1 family.
RefSeq proteins (1): NP_057152* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011990 | TPR-like_helical_dom_sf | Homologous_superfamily |
| IPR016543 | Fis1 | Family |
| IPR028058 | Fis1_TPR_N | Repeat |
| IPR028061 | Fis1_TPR_C | Repeat |
| IPR033745 | Fis1_cytosol | Domain |
Pfam: PF14852, PF14853
UniProt features (27 total): mutagenesis site 8, helix 8, strand 3, topological domain 2, modified residue 2, chain 1, sequence conflict 1, transmembrane region 1, repeat 1
Structure
Experimental structures (PDB)
12 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9AYD | X-RAY DIFFRACTION | 1.53 |
| 7YA9 | X-RAY DIFFRACTION | 1.7 |
| 8U1Z | X-RAY DIFFRACTION | 1.85 |
| 9AYE | X-RAY DIFFRACTION | 1.9 |
| 9AVB | X-RAY DIFFRACTION | 1.95 |
| 1NZN | X-RAY DIFFRACTION | 2 |
| 9AVC | X-RAY DIFFRACTION | 2.09 |
| 7YKA | X-RAY DIFFRACTION | 2.3 |
| 9AVE | X-RAY DIFFRACTION | 2.37 |
| 9AVD | X-RAY DIFFRACTION | 2.51 |
| 8XWX | X-RAY DIFFRACTION | 2.69 |
| 1PC2 | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y3D6-F1 | 79.66 | 0.26 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 1, 10
Mutagenesis-validated functional residues (8):
| Position | Phenotype |
|---|---|
| 77 | less than 15% of cells display fragmented mitochondria. shows greatly reduced binding to dnm1l. |
| 91 | less than 15% of cells display fragmented mitochondria. shows greatly reduced binding to dnm1l. |
| 110 | approximately 40% of cells display fragmented mitochondria. no change in binding to dnm1l. |
| 149 | protein localizes to both mitochondrion and endoplasmic reticulum. protein localizes to endoplasmic reticulum only; when |
| 151 | protein localizes to both mitochondrion and endoplasmic reticulum. protein localizes to endoplasmic reticulum only; when |
| 14 | approximately 40% of cells display fragmented mitochondria. |
| 42 | less than 15% of cells display fragmented mitochondria. |
| 58 | less than 15% of cells display fragmented mitochondria. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9603798 | Class I peroxisomal membrane protein import |
MSigDB gene sets: 221 (showing top):
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN, GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FISSION, GOBP_REGULATION_OF_ORGANIC_ACID_TRANSPORT, GOBP_RESPONSE_TO_PEPTIDE, GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS, GOBP_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS, GOBP_PROTEIN_TARGETING, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, CAGCTG_AP4_Q5, GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS, HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
GO Biological Process (21): mitochondrial fission (GO:0000266), obsolete protein targeting to mitochondrion (GO:0006626), mitochondrion organization (GO:0007005), response to muscle activity (GO:0014850), peroxisome fission (GO:0016559), response to nutrient levels (GO:0031667), response to endoplasmic reticulum stress (GO:0034976), positive regulation of neuron apoptotic process (GO:0043525), mitochondrial fragmentation involved in apoptotic process (GO:0043653), cellular response to glucose stimulus (GO:0071333), cellular response to lipid (GO:0071396), positive regulation of mitochondrial fission (GO:0090141), cellular response to toxic substance (GO:0097237), cellular response to peptide (GO:1901653), response to fluoride (GO:1902617), negative regulation of ATP metabolic process (GO:1903579), response to flavonoid (GO:1905395), response to hypobaric hypoxia (GO:1990910), negative regulation of fatty acid transport (GO:2000192), positive regulation of intrinsic apoptotic signaling pathway (GO:2001244), apoptotic process (GO:0006915)
GO Molecular Function (4): lipid binding (GO:0008289), identical protein binding (GO:0042802), molecular adaptor activity (GO:0060090), protein binding (GO:0005515)
GO Cellular Component (7): mitochondrion (GO:0005739), mitochondrial outer membrane (GO:0005741), peroxisome (GO:0005777), peroxisomal membrane (GO:0005778), cytosol (GO:0005829), membrane (GO:0016020), protein-containing complex (GO:0032991)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Protein localization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular response to chemical stimulus | 3 |
| binding | 3 |
| organelle fission | 2 |
| cytoplasm | 2 |
| cellular anatomical structure | 2 |
| mitochondrion organization | 1 |
| organelle organization | 1 |
| response to activity | 1 |
| peroxisome organization | 1 |
| response to stimulus | 1 |
| cellular response to stress | 1 |
| positive regulation of apoptotic process | 1 |
| regulation of neuron apoptotic process | 1 |
| neuron apoptotic process | 1 |
| apoptotic mitochondrial changes | 1 |
| intracellular glucose homeostasis | 1 |
| response to glucose | 1 |
| cellular response to hexose stimulus | 1 |
| response to lipid | 1 |
| mitochondrial fission | 1 |
| positive regulation of organelle organization | 1 |
| positive regulation of developmental process | 1 |
| regulation of mitochondrial fission | 1 |
| response to toxic substance | 1 |
| response to peptide | 1 |
| response to chemical | 1 |
| ATP metabolic process | 1 |
| negative regulation of purine nucleotide metabolic process | 1 |
| regulation of ATP metabolic process | 1 |
| response to oxygen-containing compound | 1 |
| response to hypoxia | 1 |
| fatty acid transport | 1 |
| negative regulation of lipid transport | 1 |
| negative regulation of organic acid transport | 1 |
| regulation of fatty acid transport | 1 |
| intrinsic apoptotic signaling pathway | 1 |
| positive regulation of intracellular signal transduction | 1 |
| positive regulation of apoptotic signaling pathway | 1 |
| regulation of intrinsic apoptotic signaling pathway | 1 |
| protein binding | 1 |
Protein interactions and networks
STRING
2390 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FIS1 | DNM1L | O00429 | 999 |
| FIS1 | DNM1 | Q05193 | 997 |
| FIS1 | DENR | O43583 | 995 |
| FIS1 | BCAP31 | P51572 | 995 |
| FIS1 | TBC1D15 | Q8TC07 | 994 |
| FIS1 | MFF | Q9GZY8 | 989 |
| FIS1 | MFN2 | O95140 | 986 |
| FIS1 | TBC1D17 | Q9HA65 | 962 |
| FIS1 | PEX11A | O75192 | 961 |
| FIS1 | VDAC1 | P21796 | 959 |
| FIS1 | MARCHF5 | Q9NX47 | 953 |
| FIS1 | MFN1 | Q8IWA4 | 929 |
| FIS1 | MIEF2 | Q96C03 | 924 |
| FIS1 | MIEF1 | Q9NQG6 | 922 |
| FIS1 | PINK1 | Q9BXM7 | 918 |
IntAct
156 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TUBA1C | TXNDC9 | psi-mi:“MI:0914”(association) | 0.730 |
| MIEF1 | DNM1L | psi-mi:“MI:0914”(association) | 0.690 |
| FIS1 | psi-mi:“MI:0407”(direct interaction) | 0.650 | |
| FIS1 | psi-mi:“MI:0407”(direct interaction) | 0.650 | |
| FIS1 | BCAP31 | psi-mi:“MI:0915”(physical association) | 0.600 |
| BCAP31 | FIS1 | psi-mi:“MI:0915”(physical association) | 0.600 |
| BCAP31 | FIS1 | psi-mi:“MI:0403”(colocalization) | 0.600 |
| FIS1 | BCAP31 | psi-mi:“MI:0914”(association) | 0.600 |
| CASP8 | BCAP31 | psi-mi:“MI:0915”(physical association) | 0.590 |
| FIS1 | KASH5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KASH5 | FIS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FIS1 | FFAR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FIS1 | SLC14A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM210B | FIS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM14B | FIS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FFAR2 | FIS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMPPE | FIS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC14A1 | FIS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ERGIC3 | FIS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (245): CCDC155 (Two-hybrid), FIS1 (Two-hybrid), FIS1 (Affinity Capture-MS), FIS1 (Affinity Capture-MS), FIS1 (Affinity Capture-MS), FIS1 (Affinity Capture-RNA), FIS1 (Affinity Capture-MS), FIS1 (Co-crystal Structure), DNM1L (Affinity Capture-Western), FIS1 (Affinity Capture-Western), FIS1 (Reconstituted Complex), FIS1 (Co-fractionation), FIS1 (Affinity Capture-Western), FIS1 (Two-hybrid), FIS1 (Two-hybrid)
ESM2 similar proteins: A0AVF1, A1Z6M6, A1Z8E9, B5X0I6, B7YZT2, H9IWW7, O13754, O14225, O42668, O62246, O74432, P0CN70, P0CN71, P33313, P40515, P84817, Q03560, Q20255, Q20291, Q3T0I5, Q4P7J4, Q4R7Z9, Q5AFF7, Q5FWP8, Q5U2N8, Q61LA1, Q6AHP8, Q6BLG8, Q6CFJ0, Q6CTB6, Q6CU37, Q6FIQ1, Q6GKV1, Q6INC1, Q751P7, Q75AI5, Q7RXQ1, Q8BS45, Q8NDW8, Q8SYD0
Diamond homologs: B7YZT2, P0CN70, P0CN71, P40515, P84817, Q20291, Q2H047, Q2UF96, Q3T0I5, Q4IBU4, Q4P7J4, Q4X0I8, Q5AFF7, Q5AZQ5, Q6AHP8, Q6BLG8, Q6CFJ0, Q6FIQ1, Q6WRS2, Q75AI5, Q7S8M1, Q9CQ92, Q9Y3D6, Q6CU37, Q94CK3, Q9M1J1, Q9USZ8
SIGNOR signaling
3 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MARCHF5 | “down-regulates quantity by destabilization” | FIS1 | polyubiquitination |
| FIS1 | up-regulates | Mitochondrial_fission | |
| MARCHF5 | “down-regulates quantity by destabilization” | FIS1 | ubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
34 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 27 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
884 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:101239899:TCCAT:T | acceptor_gain | 1.0000 |
| 7:101239900:CCAT:C | acceptor_gain | 1.0000 |
| 7:101239900:CCATC:C | acceptor_gain | 1.0000 |
| 7:101239901:CAT:C | acceptor_gain | 1.0000 |
| 7:101239901:CATC:C | acceptor_gain | 1.0000 |
| 7:101239902:AT:A | acceptor_gain | 1.0000 |
| 7:101239903:TC:T | acceptor_loss | 1.0000 |
| 7:101239904:C:CC | acceptor_gain | 1.0000 |
| 7:101240245:TTCC:T | acceptor_loss | 1.0000 |
| 7:101240247:CCTGC:C | acceptor_loss | 1.0000 |
| 7:101240248:CTGCG:C | acceptor_loss | 1.0000 |
| 7:101240249:T:A | acceptor_loss | 1.0000 |
| 7:101240825:CTCAC:C | donor_loss | 1.0000 |
| 7:101240827:CACCT:C | donor_loss | 1.0000 |
| 7:101240828:A:AC | donor_gain | 1.0000 |
| 7:101240828:A:C | donor_loss | 1.0000 |
| 7:101240829:C:CC | donor_gain | 1.0000 |
| 7:101240902:CAGCT:C | acceptor_gain | 1.0000 |
| 7:101240903:AGCT:A | acceptor_gain | 1.0000 |
| 7:101240905:CT:C | acceptor_gain | 1.0000 |
| 7:101240907:C:CA | acceptor_loss | 1.0000 |
| 7:101240907:C:CC | acceptor_gain | 1.0000 |
| 7:101240908:T:A | acceptor_loss | 1.0000 |
| 7:101240918:C:CT | acceptor_gain | 1.0000 |
| 7:101244005:AC:A | donor_gain | 1.0000 |
| 7:101244006:CC:C | donor_gain | 1.0000 |
| 7:101244137:CTT:C | acceptor_gain | 1.0000 |
| 7:101244144:C:CT | acceptor_gain | 1.0000 |
| 7:101244146:C:CT | acceptor_gain | 1.0000 |
| 7:101244147:A:T | acceptor_gain | 1.0000 |
AlphaMissense
973 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:101239846:G:T | A140D | 1.000 |
| 7:101239855:G:T | A137E | 1.000 |
| 7:101239861:C:T | G135D | 1.000 |
| 7:101239862:C:G | G135R | 1.000 |
| 7:101239867:G:T | A133D | 1.000 |
| 7:101239874:C:G | G131R | 1.000 |
| 7:101239876:C:T | G130E | 1.000 |
| 7:101239877:C:G | G130R | 1.000 |
| 7:101239877:C:T | G130R | 1.000 |
| 7:101239882:A:T | I128N | 1.000 |
| 7:101239885:G:T | A127D | 1.000 |
| 7:101244025:C:G | G54R | 1.000 |
| 7:101244060:A:G | L42P | 1.000 |
| 7:101239828:G:T | A146D | 0.999 |
| 7:101239834:C:T | G144E | 0.999 |
| 7:101239837:A:T | I143N | 0.999 |
| 7:101239843:C:T | G141E | 0.999 |
| 7:101239844:C:G | G141R | 0.999 |
| 7:101239844:C:T | G141R | 0.999 |
| 7:101239852:C:T | G138E | 0.999 |
| 7:101239853:C:G | G138R | 0.999 |
| 7:101239853:C:T | G138R | 0.999 |
| 7:101239864:A:C | L134R | 0.999 |
| 7:101239864:A:T | L134Q | 0.999 |
| 7:101239873:C:T | G131D | 0.999 |
| 7:101239879:A:T | V129E | 0.999 |
| 7:101239886:C:G | A127P | 0.999 |
| 7:101239891:C:T | G125D | 0.999 |
| 7:101239892:C:G | G125R | 0.999 |
| 7:101240174:A:G | L110P | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000034776 (7:101243397 G>A), RS1000310810 (7:101246796 C>G,T), RS1000444470 (7:101241523 A>G), RS1001297008 (7:101245295 T>A), RS1001709686 (7:101244885 G>C), RS1001890828 (7:101239546 G>A), RS1002109137 (7:101246008 C>T), RS1002270058 (7:101244747 G>GCTCA), RS1002302716 (7:101244547 T>C,G), RS1002323532 (7:101239755 G>A,C,T), RS1002466145 (7:101245610 G>A,T), RS1003276710 (7:101243349 G>C), RS1003865869 (7:101242424 C>T), RS1003895442 (7:101242637 C>A,T), RS1003925079 (7:101242966 T>C)
Disease associations
OMIM: gene MIM:609003 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007843_12 | Rheumatoid arthritis | 8.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066466 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 5.15 | Kd | 7152 | nM | CHEMBL5653589 |
| 5.15 | ED50 | 7152 | nM | CHEMBL5653589 |
PubChem BioAssay actives
1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2148387: Binding affinity to human FIS1 incubated for 45 mins by Kinobead based pull down assay | kd | 7.1522 | uM |
CTD chemical–gene interactions
73 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Hydrogen Peroxide | increases expression, affects cotreatment, affects reaction, decreases expression, decreases reaction | 3 |
| Valproic Acid | decreases expression, increases methylation, affects cotreatment, increases expression, affects expression | 3 |
| bisphenol A | decreases expression, increases expression | 2 |
| sodium arsenite | increases expression | 2 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression, increases expression | 2 |
| 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone | increases expression, decreases expression, decreases reaction | 2 |
| alpha-Chlorohydrin | decreases reaction, increases expression | 2 |
| Palmitic Acid | affects cotreatment, decreases reaction, increases expression | 2 |
| Particulate Matter | decreases expression, increases abundance, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| 2,4,6-tribromophenol | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | affects expression, affects response to substance | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sulforaphane | increases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| salvin | decreases reaction, increases expression | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, affects reaction, decreases expression, decreases reaction | 1 |
| gallocatechol | affects cotreatment, affects reaction, decreases expression, decreases reaction | 1 |
| epicatechin gallate | affects reaction, decreases expression, decreases reaction, affects cotreatment | 1 |
| sarpogrelate | decreases reaction, increases expression, increases reaction | 1 |
| benzyloxycarbonylleucyl-leucyl-leucine aldehyde | affects cotreatment, decreases expression, decreases reaction | 1 |
| 4-phenylbutyric acid | decreases reaction, increases expression | 1 |
| efavirenz | increases expression | 1 |
| 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate | affects cotreatment, decreases reaction, increases expression | 1 |
| bavachin | increases expression | 1 |
| bisphenol B | increases expression | 1 |
| pentabrominated diphenyl ether 100 | decreases expression | 1 |
| hexabrominated diphenyl ether 153 | decreases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5651429 | Binding | Binding affinity to human FIS1 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Cellosaurus cell lines
2 cell lines: 2 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_C6TX | GIBHe015-B | Embryonic stem cell | Male |
| CVCL_C9LB | WAe001-A-1N | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.